A study of the safety and immunogenicity of a new vaccine for the prevention of COVID-19 based on virus-like particles in phase I clinical trials - PDF (英语)
版权所有 © Grebennikova T.V., Zaykova O.N., Plotnikov A.A., Kostina L.V., Chernoryzh Y.Y., Eliseeva O.V., Latyshev O.E., Larichev V.F., Fedyakina I.T., Losich M.A., Kirillov I.M., Filatov I.E., Balandina M.V., Tsibezov V.V., Yurlov K.I., Lesnova E.I., Kondratieva V.M., Kozlova A.A., Baranets M.S., Gintsburg A.L., 2025
此作品已接受知识共享署名 4.0国际许可协议的许可